Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
162M
-
Number of holders
-
244
-
Total 13F shares, excl. options
-
168M
-
Shares change
-
-1.32M
-
Total reported value, excl. options
-
$2.08B
-
Value change
-
-$9.07M
-
Put/Call ratio
-
0.05
-
Number of buys
-
116
-
Number of sells
-
-105
-
Price
-
$12.39
Significant Holders of IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) as of Q4 2022
270 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK as of Q4 2022.
IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) has 244 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 168M shares
.
Largest 10 shareholders include BlackRock Inc. (25.8M shares), Sarissa Capital Management LP (16.4M shares), VANGUARD GROUP INC (14.7M shares), WELLINGTON MANAGEMENT GROUP LLP (13.3M shares), STATE STREET CORP (11.2M shares), LSV ASSET MANAGEMENT (7.93M shares), CREDIT SUISSE AG/ (5.2M shares), RENAISSANCE TECHNOLOGIES LLC (4.37M shares), BROWN CAPITAL MANAGEMENT LLC (4M shares), and MILLENNIUM MANAGEMENT LLC (3.99M shares).
This table shows the top 244 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.